Literature DB >> 21148424

A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose.

Priya Raman1, Christy Harry, Malory Weber, Irene Krukovets, Olga I Stenina.   

Abstract

OBJECTIVE: Vascular diabetic complications are associated with abnormal extracellular matrix and dysfunction of vascular cells, which later result in aberrant angiogenesis and development of atherosclerotic lesions. The tissue and cell specificity of the effects of high glucose are well recognized, but the underlying cell type-specific molecular mechanisms controlled by glucose are still unclear. We sought to identify cell type-specific mechanisms by which high glucose regulates transcription of genes in vascular cells. METHODS AND
RESULTS: Thrombospondin-1 is a potent antiangiogenic protein associated with development of several diabetic complications and regulated by high glucose in multiple cell types. We report that distinct cell type-specific mechanisms regulate thrombospondin-1 gene (THBS1) transcription in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in response to high glucose: although a proximal fragment of 280 nucleotides is sufficient to drive transcription in ECs, THBS1 was regulated cooperatively by interaction between proximal (-272 to -275) and distal (-1016 to -1019) promoter elements in VSMCs. Transcription factors activated by high glucose in VSMCs were cell type-specific. The formation of a single complex interacting with both distal and proximal glucose-responsive elements of THBS1 promoter in VSMCs was confirmed using gel-shift assays, binding sequence decoy oligomers, and specific mutant promoter fragments.
CONCLUSIONS: Transcriptional response of vascular cells to high glucose is cell type-specific and involves activation of distinct transcription factors, providing a basis for tissue-specific changes of vasculature in diabetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148424      PMCID: PMC3865803          DOI: 10.1161/ATVBAHA.110.219675

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

Review 1.  O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.

Authors:  Lance Wells; Gerald W Hart
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

2.  Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.

Authors:  Hunjoo Ha; Mi Ra Yu; Yoon Jin Choi; Masanori Kitamura; Hi Bahl Lee
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

Review 3.  Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  Jack Lawler
Journal:  J Cell Mol Med       Date:  2002 Jan-Mar       Impact factor: 5.310

4.  Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.

Authors:  J I Barzilay; C F Spiekerman; L H Kuller; G L Burke; V Bittner; J S Gottdiener; F L Brancati; T J Orchard; D H O'Leary; P J Savage
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

5.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

6.  A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia.

Authors:  Rainer Wessely; Ludger Hengst; Birgit Jaschke; Franziska Wegener; Thomas Richter; Raffaella Lupetti; Makarios Paschalidis; Albert Schömig; Richard Brandl; Franz-Josef Neumann
Journal:  Hum Mol Genet       Date:  2003-01-15       Impact factor: 6.150

7.  Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression.

Authors:  Seung-Hoon Lee; Jung-Whan Kim; Han-Woong Lee; Yong-Suk Cho; Sun-Hee Oh; Yong-Jin Kim; Chul-Ho Jung; Wei Zhang; Je-Ho Lee
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

8.  Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat.

Authors:  Olga I Stenina; Irene Krukovets; Kai Wang; Zhongmin Zhou; Farhad Forudi; Marc S Penn; Eric J Topol; Edward F Plow
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

9.  Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells.

Authors:  Pankaj Dabir; Tina E Marinic; Irene Krukovets; Olga I Stenina
Journal:  Circ Res       Date:  2008-05-30       Impact factor: 17.367

Review 10.  Linking dioxins to diabetes: epidemiology and biologic plausibility.

Authors:  Rene B J Remillard; Nigel J Bunce
Journal:  Environ Health Perspect       Date:  2002-09       Impact factor: 9.031

View more
  8 in total

1.  Endothelial matrix assembly during capillary morphogenesis: insights from chimeric TagRFP-fibronectin matrix.

Authors:  Fumin Chang; Christopher A Lemmon; Voraphoj Nilaratanakul; Varda Rotter; Lewis Romer
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

Review 2.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

3.  The role of thrombospondin (TSP)-1 in obesity and diabetes.

Authors:  Ping Kong; Michele Cavalera; Nikolaos G Frangogiannis
Journal:  Adipocyte       Date:  2013-11-05       Impact factor: 4.534

4.  Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.

Authors:  Carlos Gonzalez-Quesada; Michele Cavalera; Anna Biernacka; Ping Kong; Dong-Wook Lee; Amit Saxena; Olga Frunza; Marcin Dobaczewski; Arti Shinde; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2013-09-30       Impact factor: 17.367

5.  Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE-/- mice.

Authors:  Rituparna Ganguly; Soumyadip Sahu; Vahagn Ohanyan; Rebecca Haney; Ronaldo J Chavez; Shivani Shah; Siri Yalamanchili; Priya Raman
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

6.  miR-467 regulates inflammation and blood insulin and glucose.

Authors:  Jasmine Gajeton; Irene Krukovets; Revanth Yendamuri; Dmitriy Verbovetskiy; Amit Vasanji; Lidiya Sul; Olga Stenina-Adognravi
Journal:  J Cell Mol Med       Date:  2021-02-10       Impact factor: 5.310

7.  Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors.

Authors:  Sukhbir Kaur; David R Soto-Pantoja; Erica V Stein; Chengyu Liu; Abdel G Elkahloun; Michael L Pendrak; Alina Nicolae; Satya P Singh; Zuqin Nie; David Levens; Jeffrey S Isenberg; David D Roberts
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 8.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.